Scarica l'app Stockscreener
76.13
1.87%
1.40
Dopo l'orario di chiusura:
76.13
Precedente Chiudi:
$74.73
Aprire:
$74.49
Volume 24 ore:
1.35M
Relative Volume:
0.96
Capitalizzazione di mercato:
$13.18B
Reddito:
$8.28B
Utile/perdita netta:
$1.43B
Rapporto P/E:
9.3249
EPS:
8.1642
Flusso di cassa netto:
$-203.00M
1 W Prestazione:
+2.31%
1M Prestazione:
+8.66%
6M Prestazione:
-4.25%
1 anno Prestazione:
+1.91%
Intervallo 1D:
$72.74
$76.30
Intervallo di 1 settimana:
$72.74
$76.47
Portata 52W:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Nome
Solventum Corp
Settore
Industria
Telefono
651-733-1110
Indirizzo
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
76.13 | 13.18B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
449.03 | 155.80B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
146.95 | 39.22B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.28 | 32.17B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.25 | 30.46B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
209.86 | 29.61B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-24 | Iniziato | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-12-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-09-11 | Iniziato | Jefferies | Hold |
| 2025-07-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Aggiornamento | Argus | Hold → Buy |
| 2025-06-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-10-08 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | Piper Sandler | Neutral |
| 2024-09-26 | Iniziato | Wolfe Research | Peer Perform |
| 2024-09-05 | Iniziato | BTIG Research | Neutral |
| 2024-06-24 | Iniziato | Argus | Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2024-05-10 | Iniziato | BofA Securities | Neutral |
| 2024-04-10 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Iniziato | Wells Fargo | Equal Weight |
| 2024-04-02 | Iniziato | Edward Jones | Hold |
Mostra tutto
Solventum Corp Borsa (SOLV) Ultime notizie
Solventum Shareholders Back Board, Pay and Auditor Choices - TipRanks
Solventum (NYSE: SOLV) shareholders approve directors, pay plan and PwC auditor - Stock Titan
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the conglomerate - AD HOC NEWS
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
What Are Wall Street Analysts' Target Price for Solventum Stock? - Barchart.com
Will Activist Pressure and Reaffirmed EPS Guidance Reshape Solventum's (SOLV) Transformation Narrative? - simplywall.st
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) director Carlos Alban receives 3,300 restricted stock units - Stock Titan
Solventum Corp (SOLV) director receives 4,848 restricted stock units - Stock Titan
Solventum (SOLV) director Susan DeVore awarded 3,300 restricted stock units - Stock Titan
Solventum (SOLV) director receives 3,300 Restricted Stock Units as equity grant - Stock Titan
Director Glenn Eisenberg receives 3,300 Solventum (SOLV) restricted stock units - Stock Titan
Solventum (SOLV) director awarded 3,300 RSUs vesting in 2027 - Stock Titan
Solventum (SOLV) director Karen May receives grant of 3,300 RSUs - Stock Titan
Director at Solventum (NYSE: SOLV) receives 3,300 RSU equity grant - Stock Titan
Solventum Corp (SOLV) director receives grant of 3,300 RSUs vesting 2027 - Stock Titan
Solventum (SOLV) director awarded 3,300 restricted stock units vesting in 2027 - Stock Titan
Solventum (SOLV) director receives 3,300 RSU award vesting in 2027 - Stock Titan
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum (SOLV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Solventum Corporation (SOLV) Stock Analysis: Exploring a 10.53% Upside in the Healthcare Sector - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the Dow veteran - AD HOC NEWS
Wedbush initiates coverage of Solventum (SOLV) with outperform recommendation - MSN
Solventum (NYSE: SOLV) CHRO settles RSUs with tax withholding, updates share stake - Stock Titan
Solventum (SOLV) CFO exercises RSUs and uses 4,404 shares for taxes - Stock Titan
Solventum (SOLV) supply chain chief exercises 3,960 RSUs, 1,678 shares withheld for tax - Stock Titan
Solventum (NYSE: SOLV) CAO vests RSUs; 728 shares withheld for taxes - Stock Titan
Solventum (SOLV) legal chief exercises 4,488 RSUs, with 1,952 shares for tax - Stock Titan
Solventum (SOLV) CEO exercises RSUs, uses 13,503 shares for tax withholding - Stock Titan
Solventum (SOLV) CIO exercises 4,422 RSUs, withholds 2,017 shares for taxes - Stock Titan
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the industrial conglomerate - AD HOC NEWS
3M (MMM) Spin-off Solventum Receives Outperform Rating from Wedb - GuruFocus
Solventum Seen Positioned for Meaningful Re-Rating Over Next 12 to 18 Months, Wedbush Says - marketscreener.com
Wedbush Initiates Solventum at Outperform With $94 Price Target - marketscreener.com
Wedbush initiates Solventum stock coverage at Outperform By Investing.com - Investing.com Australia
Wedbush initiates Solventum stock coverage at Outperform - Investing.com
Solventum’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Solventum’s Next Chapter May Hinge On Shedding Non-Core Units - Finimize
Solventum Foundation Expands Children’s Oral Health Access - Dentistry Today
Solventum Stock Tumbles as Tariff Fears Mount - TipRanks
Solventum Foundation and America's ToothFairy Launch National Effort to Expand Access to Preventive Dental Care - Yahoo Finance
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Why Solventum’s (NYSE:SOLV) Story Deserves Closer Attention? - Kalkine Media
Transcript : Solventum Corporation Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 10 - marketscreener.com
Solventum's (NYSE:SOLV) Solid Earnings May Rest On Weak Foundations - simplywall.st
7-Day Rally Sends Solventum Stock Up 13% - Trefis
Solventum Stock On Fire: Up 13% With 7-Day Winning Streak - Trefis
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average - Yahoo Finance
Why Solventum (SOLV) Is Up 8.8% After Beating Adjusted Q1 Estimates And Reaffirming 2026 Outlook - Yahoo Finance
Is It Time To Reassess Solventum (SOLV) After Its Recent Share Price Rebound? - Yahoo Finance
Solventum Corp Azioni (SOLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):